These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 6159767)
21. Differentiation of plasma cell infiltrates in the bone marrow. A clinicopathological study on 80 patients including immunohistochemistry and morphometry. Thiele J; Arenz B; Klein H; Vierbuchen M; Zankovich R; Fischer R Virchows Arch A Pathol Anat Histopathol; 1988; 412(6):553-62. PubMed ID: 3129867 [TBL] [Abstract][Full Text] [Related]
22. Myeloma and macroglobulinemia: what are the criteria for diagnosis? Stone MJ Clin Lymphoma; 2002 Jun; 3(1):23-5. PubMed ID: 12141951 [TBL] [Abstract][Full Text] [Related]
23. The spectrum of IgM monoclonal gammopathy in 430 cases. Kyle RA; Garton JP Mayo Clin Proc; 1987 Aug; 62(8):719-31. PubMed ID: 3110508 [TBL] [Abstract][Full Text] [Related]
24. [Distinction between benign and malignant monoclonal gammopathies on the basis of bone marrow and serum studies]. Morell A; Skvaril F; Spengler G; Barandun S Schweiz Med Wochenschr; 1977 Oct; 107(41):1463. PubMed ID: 918599 [TBL] [Abstract][Full Text] [Related]
25. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452 [TBL] [Abstract][Full Text] [Related]
26. The laboratory diagnosis of plasma cell myeloma and related disorders. Nawab RA; Azar HA Orthop Clin North Am; 1979 Apr; 10(2):391-404. PubMed ID: 109804 [TBL] [Abstract][Full Text] [Related]
27. [Radioimmunoassay of beta2-microglobulin in monoclonal gammopathies (author's transl)]. Fateh-Moghadam A; Mantel W; Sandel P; von Stetten K Dtsch Med Wochenschr; 1978 Oct; 103(43):1703-6. PubMed ID: 81126 [TBL] [Abstract][Full Text] [Related]
28. Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data. The Cooperative Group for Study and Treatment of Multiple Myeloma. Riccardi A; Ucci G; Luoni R; Castello A; Coci A; Magrini U; Ascari E J Clin Pathol; 1990 Jun; 43(6):469-75. PubMed ID: 2199532 [TBL] [Abstract][Full Text] [Related]
29. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma. Jondeau K; Alterescu R; Franc B; Davi F; Massé JM; Boukour S; Le Parc JM; Cramer EM Eur J Haematol; 2006 Jul; 77(1):74-9. PubMed ID: 16827885 [TBL] [Abstract][Full Text] [Related]
30. Serum thymidine kinase in monoclonal gammopathies. A prospective study. The Cooperative Group for Study and Treatment of Multiple Myeloma. Luoni R; Ucci G; Riccardi A; Gobbi P; Avato FM; Vignale C; Ascari E Cancer; 1992 Mar; 69(6):1368-72. PubMed ID: 1540874 [TBL] [Abstract][Full Text] [Related]
31. Determination of the growth fraction in monoclonal gammopathy with the monoclonal antibody Ki-67. Lokhorst HM; Boom SE; Terpstra W; Roholl P; Gerdes J; Bast BJ Br J Haematol; 1988 Aug; 69(4):477-81. PubMed ID: 3044442 [TBL] [Abstract][Full Text] [Related]
32. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. Witzig TE; Gertz MA; Lust JA; Kyle RA; O'Fallon WM; Greipp PR Blood; 1996 Sep; 88(5):1780-7. PubMed ID: 8781435 [TBL] [Abstract][Full Text] [Related]
33. Genetic propensity to benignity in monoclonal-gammopathy. Youinou P Acta Haematol; 1979; 62(3):173-5. PubMed ID: 118617 [TBL] [Abstract][Full Text] [Related]
34. Serum beta-2-microglobulin binding activity in monoclonal gammopathy: correlative study and clinical significance. Bataille R; Vincent C; Revillard JP; Sany J Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1075-80. PubMed ID: 6352277 [TBL] [Abstract][Full Text] [Related]
35. ["Benign" monoclonal gammopathy: prognostic value of initial bone marrow study]. Grau E; Ayats R; Puig J; Domingo A; Pujol-Moix N Sangre (Barc); 1985; 30(3):308-19. PubMed ID: 4035526 [No Abstract] [Full Text] [Related]
36. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Kyle RA Am J Med; 1978 May; 64(5):814-26. PubMed ID: 645746 [TBL] [Abstract][Full Text] [Related]
37. The bone marrow in multiple myeloma: correlation of plasma cell ultrastructure and clinical state. Graham RC; Bernier GM Medicine (Baltimore); 1975 May; 54(3):225-43. PubMed ID: 167264 [TBL] [Abstract][Full Text] [Related]
38. Immunoglobulin M concentration in Waldenström macroglobulinemia: correlation with bone marrow B cells and plasma cells. de Tute RM; Rawstron AC; Owen RG Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):211-3. PubMed ID: 23523273 [TBL] [Abstract][Full Text] [Related]
39. Placental proteins as tumor markers in human monoclonal gammopathies: results in 109 patients. Morrow JS; Levin DL; Kyle RA; Rosen SW Tumour Biol; 1985; 6(3):221-32. PubMed ID: 3934736 [TBL] [Abstract][Full Text] [Related]
40. Fluorometric determinations of the relative immunoglobulin content of plasma cells of patients with monoclonal gammopathy. Kühner U; Barandun S; Morell A; Riesen W; Skvaril F; Wagner HP Med Pediatr Oncol; 1978; 4(2):115-21. PubMed ID: 96324 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]